Clinical Pharmacokinetics

, Volume 32, Issue 2, pp 174–174 | Cite as

The author’s reply

  • Carlo Campana


Simvastatin Pravastatin Lovastatin Primary Hypercholesterolaemia Transplant Recip 


  1. 1.
    Hsu I, Spinier SA, Johnson NE. Comparative evaluation of the safety and efficacy of HMG-CoA-reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacother 1995; 29: 743–59PubMedGoogle Scholar
  2. 2.
    The Simvastatin Pravastatin Study Group. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. Am J Cardiol 1993; 71: 1408–14CrossRefGoogle Scholar
  3. 3.
    Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1997

Authors and Affiliations

  • Carlo Campana
    • 1
  1. 1.Division of CardiologyIRCCS Policlinico S MatteoPiazzale GolgiItaly

Personalised recommendations